Health Condition 1: null- eczematous disorder with underlying tinea/yeast infection
Conditions
Interventions
Intervention1: A combination of clobetasol, neomycin and miconazole: combination of clobetasol, neomycin and miconazole ) to be applied twice daily to the affected areas for 1 week
Control Interven
Sponsors
Abbott Healthcare Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: •Patients aged 18 years and above diagnosed with any type of eczematous disorder associated presenting clinical features of underlying tinea/yeast infection •Patients who agree to adhere to the study design •Patients who give their consent for participation in this study
Exclusion criteria
Exclusion criteria: •Pregnant or lactating females •Indications for use of systemic therapy •Patients sensitive to corticosteroids •Patients who have immune deficiency, hepatic or renal impairment •Patients who have been on any therapy within 1 month prior to enrollment in the study •Patients who are using any other concomitant therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Improvement in clinical score from baselineTimepoint: Baseline, Day3, Day5 and Day7 | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Improvement in scaling and inflammation â?¢ Improvement in burning and itching â?¢ Adverse event assessment â?¢ Acceptability of the treatment â?¢ Tolerance of the treatment â?¢ Global assessment for efficacy by Investigator and Patient â?¢ Global assessment for tolerability by Investigator and Patient Timepoint: Baseline, Day3, Day5 and Day7 | — |
Countries
India
Contacts
Public ContactMrManoj Prabhu
Abbott Healthcare Pvt Ltd
Outcome results
None listed